Laserscope Announces Intended Resignation of Board Member
December 15 2005 - 4:05PM
PR Newswire (US)
SAN JOSE, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Laserscope
(NASDAQ:LSCP), a pioneer in the development and commercialization
of minimally-invasive medical devices, including medical lasers and
advanced fiber-optic delivery devices, announced today that Robert
Pearson, a member of the Board of Directors (the "Board") of
Laserscope (the "Company"), and the Chairman of its Audit
Committee, announced his intention to resign from the Board
effective upon the filing of the Company's Annual Report on Form
10-K for the year ended December 31, 2005, which is expected in
March 2006. Mr. Pearson, who has been a member of the Company's
Board of Directors since 2002, is resigning for personal reasons.
The Company plans to fill the vacancy created by Mr. Pearson's
departure. Robert Pressley, Chairman of Laserscope's Board of
Directors, said, "We are extremely grateful to Bob for his service
to Laserscope. We have benefited greatly from his wise counsel and
perspective, and we wish Bob much success in his future endeavors.
I, along with all of the Company's employees, will always be
appreciative for the support Bob provided during his years of Board
service." About Laserscope Laserscope designs, manufactures, sells
and services on a worldwide basis an advanced line of
minimally-invasive medical products including medical laser systems
and related energy delivery devices for the office, outpatient
surgical center, and hospital markets. More information about
Laserscope can be found on the Company's web site at
http://www.laserscope.com/. Safe Harbor Statement This press
release contains forward-looking information within the meaning of
Section 21E of the Securities Exchange Act of 1934, and is subject
to the safe harbor created by this section. These forward-looking
statements include statements about current and future plans
related to Laserscope's Board composition and governance. These
statements are subject to a number of risks and uncertainties,
including among others: uncertainties regarding introduction of new
technologies competitive to Laserscope's products and the degree to
which the Company's current and new products are accepted by
customers, which could affect the level of demand for our products;
uncertainties regarding our ability to compete with companies that
have significantly greater financial, technical, research and
development, manufacturing and marketing resources than we have;
and uncertainties that new products will receive regulatory
approval in applicable jurisdictions. Actual results may differ
materially due to these and other factors. The matters discussed in
this press release also involve risks and uncertainties described
from time to time in Laserscope's filings with the Securities and
Exchange Commission. In particular, see the Risk Factors described
in Laserscope's most recent Quarterly Report on Form 10-Q and
Annual Report on Form 10-K. Copies of Laserscope's public
disclosure filings with the SEC, including the most recent Annual
Report on Form 10-K and the most recent forms 10-Q are available
upon request from its Investor Relations Department at its website
at http://www.laserscope.com/ and at the SEC's website:
http://www.sec.gov/. Laserscope assumes no obligation to update the
forward-looking information contained in this press release. At
Laserscope: At Financial Relations Board: Eric Reuter, President
& CEO Tricia Ross, Investor/Analyst Contact Derek Bertocci, CFO
(617) 520-7064 (408) 943-0636 Laurie Berman, General Inquiries
(310) 854-8315 DATASOURCE: Laserscope CONTACT: Eric Reuter,
President & CEO, or Derek Bertocci, CFO, both of Laserscope,
+1-408-943-0636; or Investors/Analysts, Tricia Ross,
+1-617-520-7064, or General Inquiries, Laurie Berman,
+1-310-854-8315, both of Financial Relations Board, for Laserscope
Web site: http://www.laserscope.com/
Copyright
Laserscope (NASDAQ:LSCP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Laserscope (NASDAQ:LSCP)
Historical Stock Chart
From Jul 2023 to Jul 2024